文献速递妇产影像外周血管介入US

与妊娠物残留相关的子宫肌层血供增强患者的诊断与管理

Diagnosis and management of patients with enhanced myometrial vascularity associated with retained products of conception.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-08-06

本研究回顾性分析2015年8月至2017年8月间31例妊娠物残留伴子宫肌层血供明显增强(类似动静脉畸形)的患者,均行刮宫术,评估失血量与并发症。结果显示估计失血量从可忽略至最多400 mL,无术中并发症,仅1例因疑似子宫内膜炎接受治疗。作者认为刮宫术(可辅以超声引导或宫腔镜)是安全的治疗选择。

要点

  • 妊娠物残留可伴子宫肌层血供明显增强,彩色/能量多普勒可主观评估血供程度与范围。
  • 31例中14例血供增强区宽度≥20 mm,最大径10–53 mm。
  • 刮宫术估计失血量可忽略至最多400 mL,无术中并发症。

核心结论

  • 妊娠物残留相关的子宫肌层血供增强经刮宫术(可辅以超声引导或宫腔镜)治疗是安全的选择,术中无并发症,估计失血量可忽略至最多400 mL。

研究设计与样本

  • 回顾性病历复习研究,纳入2015年8月至2017年8月就诊于本超声单元的31例妊娠物残留伴子宫肌层血供增强患者,采用彩色/能量多普勒主观评估血供程度与范围,所有患者行刮宫术并复习手术记录与病历。

关键影像表现/征象

  • 子宫肌层血供增强区最大径10–53 mm,其中14/31例宽度≥20 mm。
  • 彩色/能量多普勒主观用于识别血供程度与范围。

诊断标准与关键数值

  • 血供增强区宽度≥20 mm者14/31例。
  • 估计术中失血量从可忽略至最多400 mL。
  • 无术中并发症,1例因疑似子宫内膜炎接受治疗。

临床应用与阅片要点

  • 31例中15例行标准刮宫术、13例行超声引导刮宫术、3例行宫腔镜。
  • 作者认为刮宫术可能辅以超声引导或宫腔镜是安全的治疗选择。
  • 原文提到部分研究将妊娠物残留相关的子宫肌层血供增强描述为「获得性动静脉畸形」,并有些推荐子宫动脉栓塞治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the complication rate, including estimated amount of blood loss, in patients undergoing dilation and curettage (D&C) for the treatment of retained products of conception with markedly enhanced myometrial vascularity mimicking arteriovenous malformation.

METHODS: This was a retrospective medical-records review study of patients with retained products of conception with enhanced myometrial vascularity presenting to our ultrasound unit between August 2015 and August 2017. Color/power Doppler imaging was used subjectively to identify the degree and extent of vascularity. All patients underwent D&C, and their operative reports and medical records were reviewed to see if ultrasound guidance was used, to ascertain estimated blood loss and to identify complications during or after the procedure.

RESULTS: The study group included 31 patients, of whom seven had retained products of conception after a vaginal delivery and 24 had retained products of conception after a first-trimester termination or miscarriage. The largest dimension of the region of enhanced myometrial vascularity ranged from 10 mm to 53 mm, with 14/31 having a width of ≥ 20 mm. Fifteen patients underwent a standard D&C procedure, 13 an ultrasound-guided procedure and three hysteroscopy. Estimated operative blood loss varied from negligible to a maximum of 400 mL. There were no intraoperative complications, although one patient was treated for presumed endometritis.

CONCLUSIONS: An increasing number of studies describe the enhanced myometrial vascularity associated with retained products of conception as 'acquired arteriovenous malformation', with some recommending management with uterine-artery embolization. Our study demonstrates that the enhanced myometrial vascularity is associated with retained products of conception, and surgical removal by D&C, possibly with the aid of ultrasound guidance or hysteroscopy, is a safe treatment option. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Groszmann YS, Healy Murphy AL, Benacerraf BR, et al. Diagnosis and management of patients with enhanced myometrial vascularity associated with retained products of conception. Ultrasound Obstet Gynecol. 2018. PMID: 29124818. doi:10.1002/uog.18954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。